EU Malaria Fund: AchilleS Vaccines, Magnetrap, KELTIC Pharma and Sumaya receive a total of EUR 17.6 million to develop malaria vaccines, diagnostics and therapeutics.
Berlin, September 3, 2021 This week, AchilleS Vaccines S.r.l., Magnetrap SA, KELTIC Pharma Therapeutics Ltd and Sumaya Biotech GmbH & Co.